Vaccine equity is very important; only the Universal Immunisation Programme can achieve it: Gagandeep Kang
As the principal investigator in the phase III trials of the Rotovac vaccine to prevent rotavirus related gastroenteritis Gagandeep Kang is “very excited” with the publication of the results of a study that established the effectiveness of the vaccine, country wide. Currently director of the global health team at the Bill and Melinda Gates Foundation, responsible for enterics, diagnostics, epidemiology and genomics portfolio, Dr. Kang, in a previous position with the Christian…
